Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

MLA

Cometta, Alain, et al. “Monotherapy with Meropenem versus Combination Therapy with Ceftazidime plus Amikacin as Empiric Therapy for Fever in Granulocytopenic Patients with Cancer.” Antimicrobial Agents and Chemotherapy, 40 (5, 1996. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1363743090&authtype=sso&custid=ns315887.

APA

Cometta, A., Calandra, T., Gaya, H., Zinner, S. H., De Bock, R., Del Favero, A., Bucaneve, G., Crokaert, F., Kern, W. V., Klastersky, J., Langenaeken, J., Micozzi, A., Padmos, A., Paesmans, M., Viscoli, C., Glauser, M., Martino, P., Caballero, D., Engelhard, D., … Berneman, Z. N. (1996). Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy, 40 (5.

Chicago

Cometta, Alain, Thierry Calandra, Harold Gaya, Stephen H. Zinner, Robrecht De Bock, Albano Del Favero, Giampaolo Bucaneve, et al. 1996. “Monotherapy with Meropenem versus Combination Therapy with Ceftazidime plus Amikacin as Empiric Therapy for Fever in Granulocytopenic Patients with Cancer.” Antimicrobial Agents and Chemotherapy, 40 (5. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1363743090&authtype=sso&custid=ns315887.